Slate Path Capital LP Quant / Systematic

Location: New York, NY

CIK: 0001559706 · Show all filings

Period: Q2 2014 (← Previous) (Next →)

Filing Date: Aug 14, 2014

Total Value: $3.578B (100.0% shares, 0.0% debt)

Holdings (18)

SPY SPDR S&P 500 ETF TR 49.8%
Value $1.781B Shares 9,100,000 Est. Cost Unrealized
SPY SPDR S&P 500 ETF TR 10.1%
Value $362M Shares 1,850,000 Est. Cost Unrealized
POWERSHARES QQQ TRUST 6.6%
Value $235M Shares 2,500,000 Est. Cost Unrealized
CHARTER COMMUNICATIONS INC D 4.0%
Value $144M Shares 910,000 Est. Cost $124.71 Unrealized
ISRG INTUITIVE SURGICAL INC 3.6%
Value $129M Shares 314,000 Est. Cost $44.11 Unrealized 0.0%
BARRICK GOLD CORP 3.6%
Value $129M Shares 7,027,000 Est. Cost $17.83 Unrealized
PANDORA MEDIA INC 3.2%
Value $113M Shares 3,825,000 Est. Cost $26.00 Unrealized
AIG AMERICAN INTL GROUP INC 3.0%
Value $107M Shares 1,960,000 Est. Cost $32.51 Unrealized +24.3%
SIRIUS XM HLDGS INC 2.8%
Value $100M Shares 28,940,000 Est. Cost $3.49 Unrealized
CTRIP COM INTL LTD 2.6%
Value $93.82M Shares 1,465,000 Est. Cost $50.52 Unrealized
ALLE ALLEGION PUB LTD CO 2.6%
Value $93.52M Shares 1,650,000 Est. Cost $46.47 Unrealized 0.0%
ENDO INTL PLC 2.2%
Value $77.72M Shares 1,110,000 Est. Cost $68.65 Unrealized
YOUKU TUDOU INC 1.5%
Value $52.61M Shares 2,205,000 Est. Cost $23.86 Unrealized
MPC MARATHON PETE CORP 1.1%
Value $37.86M Shares 485,000 Est. Cost $26.84 Unrealized +16.1%
PBF PBF ENERGY INC 1.1%
Value $37.84M Shares 1,420,000 Est. Cost $27.93 Unrealized +5.9%
ALNY ALNYLAM PHARMACEUTICALS INC 1.1%
Value $37.78M Shares 598,000 Est. Cost $39.51 Unrealized +50.4%
QUESTCOR PHARMACEUTICALS INC 1.0%
Value $34.22M Shares 370,000 Est. Cost Unrealized
CLIFFS NAT RES INC 0.4%
Value $12.87M Shares 855,000 Est. Cost $15.05 Unrealized